Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sosei Group Corp Establishes New Subsidiary -- Nikkan Kogyo Shimbun


Tuesday, 4 Jun 2013 08:00pm EDT 

Nikkan Kogyo Shimbun reported that Sosei Group Corp has resolved to invest in the regenerative medicine fund run by the newly-established subsidiary Sosei Corporate Venture Capital (“Sosei CVC”). Sosei Group will pursue a new venture through Sosei CVC. Sosei CVC is engaged in managing of a new fund for the purpose of investing in companies developing Regenerative Medicine technologies (including but not limited to tissue engineering and cell therapy/regenerative cell therapy, and related devices/equipment). Sosei CVC was established on May 29, 2013. 

Company Quote

4280.0
180.0 +4.39%
22 Oct 2014